Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Aikon Biopharmaceutical R&D is a specialized biotechnology and chemical services company based in Nanjing, China. Founded in 2009, the company focuses on the research, development, and production of high-quality pharmaceutical reagents, fine chemicals, and advanced intermediates, with a particular expertise in cyclo-compounds, PEG derivatives, and heterocyclic building blocks. Aikon provides comprehensive CRO and CMO services, including custom synthesis, third-party analytical testing via chromatography and mass spectrometry, and international logistics for the pharmaceutical industry. While primarily a service and reagent provider, the company also engages in early-stage drug discovery and optimization using computer-aided drug design to support the development of innovative therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Aikon Biopharmaceutical R&D.